Lieff Cabraser partner David Rudolph will be a speaker at the Practising Law Institute’s California Privacy Law 2023 event on Thursday, October 26, 2023. The half day program will be held in-person in San Francisco and via live webcast. David will co-lead a presentation on “The Outside Counsel Perspective,” where he will discuss key privacy litigation risks faced by companies, provide an understanding of the plaintiff perspective, and analyze what steps companies can take to minimize risk.
California Privacy Law 2023 will delve into the California Consumer Privacy Act (CCPA), currently the nation’s most robust privacy legislation, exploring its recent amendments and their implications for corporate legal responsibilities. Program attendees will learn:
- Learn the basic framework to the CCPA
- Understand compliance approaches from the in-house and regulator perspectives
- Review updates since the law went into effect January 1, 2020, as well as expert guidance on legal issues going forward, and complications by COVID-19
For more information regarding speakers, agenda, and registration, visit the Practising Law Institute website.
About David Rudolph
A partner in Lieff Cabraser’s San Francisco office, David Rudolph is a member of the firm’s Cybersecurity and Data Privacy and Antitrust and Intellectual Property practice groups. He has extensive experience litigating core technical issues in privacy cases, including in In re Anthem, Inc. Data Breach Litigation, MDL No. 2617 (N.D. Cal.), arising from a data breach that affected nearly 80 million of Anthem’s members, and in Campbell v. Facebook, Inc., No. 5:13-cv- 5996 (N.D. Cal.), in which Facebook users asserted that Facebook violated their privacy rights by scanning their private email messages.
David has represented end-payor classes in pharmaceutical antitrust litigation, including in the Cipro drug antitrust cases, the Restasis antitrust litigation, and the Generic Pharmaceuticals Price-Fixing cases. In 2017, David shared the “Outstanding Private Practice Antitrust Achievement” award from the American Antitrust Institute for his work on the Cipro case. He also represents plaintiffs in In re Domestic Airline Travel Antitrust Litigation (D.D.C.), a class action lawsuit alleging a conspiracy by United, American, Delta, and Southwest to artificially inflate domestic airline ticket prices by artificially limiting seating capacity.